Following please find a listing of federal opportunities/agency notices related to COVID-19 research funding opportunities.
Multi-agency funding opportunity list kindly put together by colleagues at the EPSCoR/IDeA Foundation. Agencies included in this list are:
- White House Office of Science and Technology
- National Science Foundation
- Health and Human Services
- Food and Drug Administration
- National Institutes of Health
- Department of Energy
- Department of Defense
- Department of Homeland Security
- Department of Justice
Amazon Web Services - AWS Diagnostic Development Initiative (DDI) - Due June 30, 2020
- The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.
Campus Consortium - C19 – Work From Home Cybersecurity Grant - Due April 3, 2020
- In light of the COVID-19 pandemic, the Work From Home Cybersecurity Grant is designed to give institutions the ability to secure access to enterprise systems and applications as students, faculty and staff take online courses and work from home. The Grant provides awarded institutions with the requisite licenses and implementation services to a comprehensive Single Sign-On (SSO) and Adaptive Multi-Factor (MFA) solution. Following the Campus Consortium’s due diligence process, grant recipients may receive up to $100,000 in software licenses, support and implementation services for a term of up to five years.
National Science Foundation - Dear Colleague Letter on the Coronavirus Disease COVID-19 - NSF 20-052
- In light of the emergence and spread of the coronavirus disease 2019 (COVID-19) in the United States and abroad, the National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
- NSF encourages the research community to respond to this challenge through existing funding opportunities. In addition, we invite researchers to use the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency with regard to availability of or access to data, facilities or specialized equipment as well as quick-response research on natural or anthropogenic disasters and similar unanticipated events. Requests for RAPID proposals may be for up to $200K and up to one year in duration.
NIH - National Institute of Allergy and Infectious Diseases (NIAID) - Multi-Pronged Response to the COVID-2019 Outbreak
- NIAID is taking several approaches to support new research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019). Click link above for details on programs.
MIT Solve Challenge - Health Security & Pandemics - closes June 18, 2020
- MIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers. At the same time, we cannot solely treat disease outbreaks reactively. Climate change and globalization leave us ever more vulnerable to future epidemics and pandemics, and it’s critical to be prepared. Solve is also seeking solutions that focus on preventative and mitigation measures that strengthen access to affordable primary healthcare systems, enhance disease surveillance systems, and improve healthcare supply chains.
NASA - Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic
- Research activities proposed must be hypothesis-driven and make quantitative connections between changes in anthropogenic forcings and/or social and economic activity and the related Earth system environmental response to the COVID-19 pandemic. Proposals should address change(s) as part of longer-term regional or global budgets and/or interconnected processes in a way that adds to our understanding of them. Proposals that simply demonstrate correlations between changed human activities and direct response of quantities viewed from space are of low priority. Applications-related proposals MUST demonstrate how NASA and related remote sensing data can characterize impacts of decisions taken or can inform public and private decision making. Proposals that cross the traditional boundary between research and applications that may serve to amplify the cross-benefits between them are welcomed; in such cases the proposals should address how both sets of objectives are addressed.
White House Office of Science and Technology Policy (OSTP) - COVID-19 Open Research Dataset (CORD-19)
- Earlier this week, the NLM released the COVID-19 Open Research Dataset (CORD-19) of scholarly literature related to COVID-19, SARS-CoV-2, and the Coronavirus group.
- The dataset is the most comprehensive machine-readable Coronavirus literature collection available for data and text mining to date, with over 29,000 articles - more than 13,000 of them full text.
- To make full of this dataset, the White House Office of Science and Technology Policy (OSTP) has issued a call for tech and AI experts to develop new text and data mining techniques that can be used to help the science community answer high-priority scientific questions related to COVID-19.